Atlas Trials

Prospective Study on the Feasibility of Plasma FLT3-Ligand Assay to Achieve a First Estimate of Its Prognostic Value on the Outcome of Patients Treated Intensively for Acute Leukemia

Clinical trial NCT02693899 · COMPLETED

Trial details

NCT number
NCT02693899
Sponsor
Nantes University Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Acute Leukemia
Start date
2016-05-27
Primary completion
2018-02-06
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.